louisiana glp-1 gastrointestinal obstruction attorney gi lawyer GLP-1 RA Lawsuit louisiana glp-1 gastric intestinal obstruction

View: 16812 Download: 278 Times Cited: 10

In a statement, the Danish company said the move would help to address "access barriers" to the medicines and "make it easier and more affordable for people in the US to get authentic, FDA-approved Wegovy and Ozempic in the way that best fits their lives." There's little doubt that one of the reasons for the move will be to try to keep pace with arch-rival Eli Lilly in the market for incretin-based therapies for obesity and T2D, particularly the strong growth of Lilly's dual GIP/GLP-1 agonist tirzepatide, whose growth rate is outstripping Novo Nordisk's products

We treat what's actually holding you back with medically supervised GLP-1 therapy and a plan built around your biology

This delay is characteristic of telogen effluvium: the metabolic stress (rapid weight loss, nutrient shift) triggers follicles to enter the resting phase, and those follicles shed 23 months later when the growth cycle resets

In September 2023, the FDA did update the semaglutide label to add ileus (a severe intestinal blockage) as a warning, demonstrating that the agency does act on emerging safety signals when the evidence supports it

Some patients feel minimal discomfort, while others may notice stronger symptoms